Published in Pharma Law Weekly, November 28th, 2006
The president & CEO of Bioniche Life Sciences, Inc., Graeme McRae, noted, "Bioniche takes its patent portfolio very seriously. We have more than 300 approved patents or pending patent applications in progress, and we are constantly adding more. This ensures the maximum opportunity for returns on marketed products."
The company has been granted a patent in the U.S. entitled "Hyaluronic acid in the treatment of cancer" (U.S. Patent No. 7125858), inventors Nigel C. Phillips and Mario...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly